The role of GPD2 and glycolysis-related genes in cholangiocarcinoma: insights into prognostic biomarkers and tumor-immune interactions
This study highlights the potential of GPD2 and the glycolysis-related gene signature as prognostic biomarkers and therapeutic targets in CCA. The signature offers insights into tumor biology, immune interactions, and potential personalized treatment strategies, paving the way for improved management of this aggressive cancer.
Authors
- Wen Qin (ORCID: https://orcid.org/0000-0002-2714-3613)
- Bo Ren (ORCID: https://orcid.org/0000-0001-8332-3611)
- Wence Zhou (ORCID: https://orcid.org/0000-0003-2573-9170)
- Weixiong Zhu (ORCID: https://orcid.org/0009-0009-7247-8111)
- Yongqing Zhao
Institutions
- Lanzhou University Second Hospital (CN)
- Gansu Provincial Center for Disease Control and Prevention (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1186/s12935-025-03965-x
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01